Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

CRY:US

10.6000 USD 0.0500 0.47%

As of 20:04:04 ET on 03/04/2015.

Snapshot for CryoLife Inc (CRY)

Open: 10.5300 Day's Range: 10.4100 - 10.7200 Volume: 64,297
Previous Close: 10.5500 52wk Range: 8.4000 - 12.2900 1-Yr Rtn: +8.26%

Stock Chart for CRY

No chart data available.
  • CRY:US 10.6000
  • 1D
  • 1M
  • 1Y
10.5500
Interactive CRY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CRY

Current P/E Ratio (ttm) 49.0820
Estimated P/E(12/2015) 176.6667
Relative P/E vs. SPX 2.6199
Earnings Per Share (USD) (ttm) 0.2160
Est. EPS (USD) (12/2015) 0.0600
Est. PEG Ratio 5.8889
Market Cap (M USD) 298.99
Shares Outstanding (M) 28.21
30 Day Average Volume 101,719
Price/Book (mrq) 2.0053
Price/Sale (ttm) 2.0063
Dividend Indicated Gross Yield 1.13%
Cash Dividend (USD) 0.0300
Dividend Ex-Date 03/11/2015
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CRY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CRY

CryoLife, Inc. cryopreserves viable human tissues for cardiovascular, vascular, and orthopedic transplant applications. The Company develops and commercializes additional implantable products and single-use medical devices. CryoLife develops bioprosthetic cardiovascular devices, including novel design stentless porcine heart valves marketed in Europe.

Steven G AndersonChairman/FounderJames Patrick Mackin "Pat"President/CEO
David Ashley LeeExec VP/CFO/COODavid P LangSenior VP:Intl Sales & Mktg
More Company Profile & Key Executives for CRY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil